Membrane glycolipids and human immunodeficiency virus infection of primary macrophages

AIDS Research and Human Retroviruses

Volumn 12, Issue 8, 1996, Pages 695-703

  Seddiki, Nabila ^a,b   Younes Chennoufi, Aména Ben ^c   Benjouad, Abdelaziz ^b   Saffar, Line ^a   Baumann, Nicole ^c   Gluckman, Jean Claude ^b   Gattegno, Liliane ^a,d  

^a UNIVERSITÉ PARIS 13   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSERM   (France)

^d Association pour la Recherche en Physiologie de l'Environnement ARPE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; GANGLIOSIDE GM3; GLYCOLIPID; GLYCOPROTEIN GP 160; VIRUS RECEPTOR;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPID COMPOSITION; MACROPHAGE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; VIRUS ADSORPTION; VIRUS CELL INTERACTION;

EID: 0029942771     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.695     Document Type: Article

References (50)

1. Klatzmann DR, McDougal JS, and Maddon PJ: The CD4 molecule and HIV infection. Immunodefic Rev 1990;2:43-66.
2. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, and Axel R: The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986;47: 333-348.
3. Tersmette M, Van Dongen JJM, Clapham PR, De Goede REY, Wolvers-Tettero ILM, Van Kessel AG, Huisman JG, Weiss RA, and Miedima F: Human immunodeficiency virus studied in CD4-expressing human-murine T-cell hybrids. Virology 1989;168:267-273.
4. Clapham PR, Blanc D, and Weiss RA: Specific surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus. Virology 1991;181:703-715.
5. Folks TM, Kessler SW, Orenstein JM, Justement JS, Jaffe ES, and Fauci AF: Infection and replication of HIV-I in purified progenitor cells of normal human bone marrow. Science 1988;242: 919-922.
6. Tateno M, Gonzalez-Scarano F, and Levy JA: Human immunodeficiency virus can infect CD4-negative human fibroblast cells. Proc Natl Acad Sci USA 1989;86:4287-4291.
7. Ikeuchi K, Kim S, Byrn RA, Golding SR, and Groopman J: Infection of nonlymphoid cells by human immunodeficiency virus type-1 or type-2. J Virol 1990;64:4226-4231.
8. Lasky LA, Nakamura G, Smith DH, Fennie C, Simasaki C, Patzer E, Berman P, Gregory T, and Capon DJ: Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 1987;50: 975-987.
9. Harouse JM, Bhat S, Spitalnik SL, Laughin M, Stefano K, Silberberg DH, and Gonzalez-Scarano F: Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 1991;253:320-323.
10. Harouse JM, Kunsch C, Hartle HT, Laughlin MA, Hoxie JA, Wigdahl B, and Gonzalez-Scarano F: CD4-independent infection of human neural cells by immunodeficiency virus type 1. J Virol 1989;63:2527-2533.
11. Bhat S, Spitalnik SL, Gonzalez-Scarano F, and Silberberg DH: Galactosylceramide or derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci USA 1991;88:7131-7134.
12. Bhat S, Menus RV, Reddy EP, Ugen KE, Srikanthan V, Williams WV, and Weiner DB: The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. AIDS Res Hum Retroviruses 1993;9:175-181.
13. Fantini J, Cook DG, Nathanson N, Spitalnik SL, and Gonzalez-Scarano F: Infection of colonic epithelial cell lines by type-1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci USA 1993;90:2700-2704.
14. Schneider-Schaulies J, Schneider-Schaulies S, Brinkman R, Tas P, Halburgge M, Walter U, Holmes HC, and Termeule V: HIV-1 gp120 receptor on CD4-negative brain cells activates a tyrosine kinase. Virology 1992;191:765-772.
15. Cook DG, Fantini J, Spitalnik SL, and Gonzalez-Scarano FJ: Binding of human immunodeficiency virus type-1 (HIV-1) gp120 to galactosylceramide (GalCer): Relationship to the V3 loop. Virology 1994;201:206-214.
16. Long D, Berson JF, Cook DJ, and Doms RW: Characterization of human immunodeficiency virus type-1 gp120 binding to liposomes containing galactosylceramide. J Virol 1994;68:5890-5898.
17. Fauci AS: The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science 1988;239:617-622.
18. Merill JE and Chen ISY: HIV-1 macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J 1991;5: 2391-2397.
19. Finbloom DS, Hoover DL, and Meltzer MS: Binding of recombinant HIV coat protein gp120 to human monocytes. J Immunol 1991;14:1316-1321.
20. Jouault T, Chapuis F, Olivier R, Parravicini C, Bahraoui E, and Gluckman JC: HIV infection of monocyte cells: Role or antibody-mediated virus binding to Fc-gamma receptors. AIDS 1989;3: 125-133.
21. Robinson WE, Montefiori DC Jr, and Mitchell WM: Complement-mediated antibody enhancement of HIV-1 infection requires CD4 and complement receptor. Virology 1990;175:600-604.
22. Seddiki N, Ramdani A, Saffar L, Portoukalian J, Gluckman JC, and Gattegno L: A monoclonal antibody directed to sulfatides inhibits the binding of human immunodeficiency virus (HIV-1) envelope glycoprotein to macrophages but not their infectivity by the virus. Biochem Biophys Acta 1994;1225:289-296.
23. Dragic T, Picard L, and Alizon M: Proteinase-resistant factors in human herythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins. J Virol 1995;69:1013-1018.
24. Ben Younès-Chennoufi A, Léger JM, Harpin ML, Bouche P, and Baumann N: Immunolocalization of IgM monoclonal antibodies to sulfated glycolipids in peripheral neuropathy associated with IgM gammopathy. J Neuroimmunol 1994;54:152.
25. Kieny MP, Lathe R, Rivière Y, Dott K, Girard M, Montagnier L, and Lecoq JP: Improved antigenicity of the HIV Env protein by cleavage site removal. Protein Eng 1988;2:219-225.
26. Fenouillet E, Clerget-Raslain B, Gluckman JC, Guétard D, Montagnier L, and Bahraoui E: Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. J Exp Med 1989;3:807-821.
27. Gartner S, Markovits P, Markovits DM, Kaplan MH, and Gallo RC: The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986;233:215-219.
28. Valentin A, Von Gegerfelt A, Matsuda S, Nilsson K, and Asjö B: In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection. J Acquir Immune Defic Syndr 1991;4:751-759.
29. Pollet S, Ermidou S, Leseaux F, Monge M, and Baumann N: Microanalysis of brain lipids: Multiple two dimensional thin-layer chromatography. J Lipid Res 1978;19:916-921.
30. Folch J, Lees M, and Sloane S: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497-509.
31. Williams MA and McCluer RH: The use of Sepak C18 cartridges during the isolation of gangliosides. J Neurochem 1980;35:266-269.
32. Svennerholm L: Quantitative estimation of sialic acid. II. A colorimetric resorcinol-hydrochloric method. Biochim Biophys Acta 1957;24:604-611.
33. Jacin H and Mishkin AR: Separation of carbohydrates on borate-impregniated silica gel G plate. J Chromatogr 1965;18:170-173.
34. Magnani JL, Nilsson B, Borckhaus M, Zopf D, Stepleewski H, and Ginsburg V: A monoclonal antibody-defined antigen associated with gastrointestinal cancer in a ganglioside containing sialylated lacto-N-fucopentose II. J Biol Chem 1982;257:14365-14369.
35. Ben Younes-Chennoufi A, Meininger V, Léger JM, Bouche P, Jauberteau MO, and Baumann N: Anti-ganglioside antibodies in motor-neuron diseases and peripheral neuropathies: Study by ELISA technique and immunodetection on thin-layer chromatography. Neurochem Int 1992;20:353-357.
36. Ghandour MS and Nussbaum JL: Oligodendrocyte cell surface recognized by a novel monoclonal antibody specific to sulfatide. J Neurochem 1994;1:13-16.
37. Zalc B, Menge M, Dupouey P, Hauw JJ, and Baumann N: Immunohistochemical localization of galactosyl and sulfogalactosylceramide in the brain of the 30 days-old mouse. Brain Res 1981;211:341-354.
38. Nakakuma H, Arai M, Kawaguchi T, Hidaka M, Sakamoto K, Iwamori M, Nagai Y, and Takatsuki K: Monoclonal antibody to galactosylceramide: Discrimination of structural difference in the ceramide moiety. FEBS Lett 1989;258:230-232.
39. McAlarney T, Apostolsky S, Lederman S, and Latov NL: Characteristics of HIV-1 gp120 glycoproteins binding to glycolipids. Neurosci Res 1994;37:453-460.
40. Hakomori S: Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem 1990;265:18713-18716.
41. Krivan HC, Olson LD, Barile MF, Ginsburg V, and Roberts DD: Adhesion of mycoplasma pneumoniae to sulfated glycolipids and inhibition by dextran sulfate. J Biol Chem 1989;264:9283-9288.
42. Brennan MJ, Hannah JH, and Leininger E: Adhesion of Bordetella pertussis to sulfatides and to the GalNAcβ4Gal sequence found in glycosphingolipids. J Biol Chem 1991;266:18827-18831.
43. Apostolski S, McAlarney T, Quattrini A, Levison SW, Rosoklija G, Lugaressi A, Corbo M, Sadiq SA, Lederman S, Hays AP, and Latov N: The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory neurons. Ann Neurol 1993;34:855-863.
44. Furuta Y, Eriksson K, Svennerholm B, Fredman P, Horal P, Jeansson S, Vahlne A, Holmgren J, and Czerkinsky C: Infection of vaginal and colonic epithelial cells by the human immunodeficiency virus type 1 is neutralized by antibodies raised against conserved epitopes in the envelope glycoprotein gp120. Proc Natl Acad Sci USA 1994;91:12559-12563.
45. Petratos S, Turnbull VJ, Papadopoulos R, and Gonzales MF: IgM antibody reactivity against myelin glycolipids in plasma samples from HIV-positive patients. J Cell Biochem Abstr Suppl 1995;21B:224.
46. Krugner-Higby L, Goff D, Edwards T, Iyer N, Neufeld J, Kute T, Morris-Natschke S, Ishaq K, Piantadosi C, and Kucera LS: Membrane-interactive phospholipids inhibit type 1-induced cell fusion and surface gp160/120 binding to monoclonal antibody. Aids Res Hum Retroviruses 1995;11:705-712.
47. Chernomorkid L, Chanturiya AN, Suss-Toby E, Nora E, and Zimmerberg J: An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J Virol 1994;68:7115-7123.
48. Sharpless N, Gilbert D, Vandercam B, Zhou JM, Verdin E, Ronnett G, Friedman E, and Dubois-Dalq M: The restricted nature of HIV-1 tropism for cultured neural cells. Virology 1992;191:813-825.
49. Parmantier E, Monge M, Yagello M, Cabon F, Demerens C, Gluckman JC, and Zalc B: HIV-1 envelope glycoprotein gp120 does not bind to galactosylceramide expressing rat oligodendrocytes. Virology 1995;206:1084-1091.
50. Constantin G, Laudanna C, Baron P, and Berton G: Sulfatides trigger cytokine gene expression and secretion in human monocytes. FEBS Lett 1994;350:66.